Philadelphia Magazine Names 133 Fox Chase Cancer Center Physicians ‘Top Doctors’

Top Doctors 2024
One hundred and thirty-three Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2024.

PHILADELPHIA (April 22, 2024) — One hundred and thirty-three Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2024. Physicians on the list were nominated by a national survey of their professional peers.

“Once again, Philadelphia magazine’s ‘Top Doctors’ list has recognized Fox Chase’s physicians for the high-quality care and expertise that they provide for their patients. The publication has recognized 133 Fox Chase physicians, which is a significant increase over last year and over previous years,” said Robert Uzzo, MD, MBA, FACS, President and CEO of Fox Chase.

“This designation is particularly significant because this recognition is based on professional peer nominations. The inclusion of our physicians reflects the high regard in which they are held for their expertise and career achievements. It speaks volumes about the superb, comprehensive cancer care that Fox Chase offers patients” Uzzo added.

The 2024 Fox Chase Cancer Center “Top Doctors” are:


Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427